Expert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias
Experts discuss results and implications from 3 of the key studies in acute myeloid leukemia and chronic myeloid leukemia from the virtual Hematology 2020 meeting, including magrolimab in AML, the STAMP inhibitor asciminib in CML (the ASCEMBL trial), and optimal dosing for ponatinib in CML (the OPTIC trial).
You May Also Like
Kabbalah: Daily Lessons | mp4 #kab_eng
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"

sarah marie anderson's podcast
sarah marie anderson

Motivational Speeches
Motivationly

שפות שלי: לימוד אנגלית
אריאל וג'וש | שפות שלי

I Love Public Speaking with Bishal Sarkar
Mr. Bishal Sarkar
Каббала: Ежедневные уроки | mp4 #kab_rus
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Cabalá: Lecciones Diarias | mp4 #kab_spa
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
קבלה מדיה | mp3 #kab_heb
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Cabalá Media | mp4 #kab_spa
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Каббала Медиа | mp3 #kab_rus
Bnei Baruch Kabbalah Education and Research Institute, Бней Барух – Ассоциация "Каббала Ла-Ам"
Community discussion